Evergraf 0.25mg Tablet
Item requires a valid prescription
Manufactured By MANKIND PHARMACEUTICALS LIMITED
Composition EVEROLIMUS
Rs 568.00
MRP Rs 700.59
(19% OFF)
Includes all taxes
Package SIZE
( 10 TABLET(s) IN A STRIP )
100% Authentic
Products
Free
Shipping*
Products
Return Policy
Description: Evergraf 0.25mg tablet is an antineoplastic medicine that belongs to the class of mTOR kinase inhibitors. Its Evergraf 0.25 mg composition includes everolimus as the active ingredient, which works by slowing the growth and spread of abnormal cells. It is commonly prescribed in conditions such as advanced breast cancer, renal cell carcinoma, pancreatic neuroendocrine tumours, and subependymal giant cell astrocytoma, which affects structures within the brain. In clinical practice, Mankind Evergraf 0.25 mg is also used in transplant medicine, including Evergraf 0.25 mg in kidney transplant, to help suppress immune activity and prevent rejection under specialist supervision.
In oncology settings, doctors may recommend Evergraf 0.25 mg for breast cancer when the disease is hormone receptor–positive and has progressed despite other treatments. Because this medicine affects cell growth and immune responses, maintaining good oral hygiene is essential. Issues such as Evergraf 0.25 mg and mouth ulcers are well recognised during therapy, and regular dental care along with prescribed mouthwashes can help reduce discomfort and prevent infections.
Uses / Indications: Evergraf 0.25 mg uses: • Advanced breast cancer • Advanced renal cell carcinoma • Advanced pancreatic neuroendocrine tumours • Treatment of subependymal giant cell astrocytoma
- Product composition:
- EVEROLIMUS
Interactions / Warnings: • Store Evergraf 0.25mg Tablet 10'S in the original package at room temperature (20°C to 25°C).
• Keep it out of reach from children.
- Pregnancy interaction:
- Pregnancy (unsafe): Evergraf 0.25mg tablet is not recommended for pregnant women as it may cause fetal harm. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
- Expert advice:
- • Evergraf 0.25mg tablet may harm an unborn baby, so inform your healthcare provider if you are pregnant or planning to conceive. • A pregnancy test is usually required before starting this treatment. • Use effective birth control during treatment and continue it for 8 weeks after the last dose, as advised by your doctor. • This medicine can pass into breast milk, so breastfeeding is not recommended while on treatment. • Mouth ulcers or sores are common during therapy; your doctor may prescribe a mouthwash to help prevent and manage these symptoms.
- Side Effects:
- Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Evergraf 0.25 mg side effects are Serious • Difficulty breathing, or swallowing • Swelling of face, lips, tongue, throat • Severe itching, red rash, raised bumps Common • Infection (chills, increased temperature) • Coughing • Wheezing • Excessive thirst • High urine output or severely decreased urine output • Tiredness • Bleeding • Increased appetite with weight loss
- How to use:
- Take the Evergraf 0.25mg tablet as advised by your physician. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.
- How it works:
- Evergraf 0.25mg tablet inhibits the activity of a protein called mammalian target of rapamycin (mTOR), which regulates cell growth. This drug can slow the growth of abnormal cancer cells by blocking the mTOR protein and helps to reduce the size of tumours and improve outcomes in patients.
- Faq for medicine:
- Q: What you should know before taking Evergraf 0.25mg tablet? A: Before taking Evergraf 0.25mg tablet, it is important to know that your risk of getting bacterial or viral infection increases with this treatment. If you have been infected with Hepatitis B, this drug increases the chances of reinfection. Tell your healthcare provider if you experience fever, chills, cough, yellowing of the skin, joint pain, or swelling during this treatment. Q: Is it safe to use Evergraf 0.25mg tablet during pregnancy? A: Evergraf 0.25mg tablets have the tendency to cause harm to the unborn fetus. Inform your healthcare provider before starting this treatment if you are pregnant, or planning for pregnancy. Your healthcare provider will conduct a pregnancy test before you start treatment with this drug. Q: What are the side effects of Evergraf 0.25mg Tablet? A: The common side effects that are likely to occur while you are on the treatment with Evergraf 0.25mg tablet are fever, chills, skin rash, joint pain, swelling, tiredness, loss of appetite, high risk of infection, mouth ulcers, and difficulty breathing. Q: Is it safe to undergo surgery while on treatment with Evergraf 0.25mg tablet? A: Evergraf 0.25mg tablet may lead to poor wound healing ability. Consult your healthcare provider and stop taking this tablet at least one week before planned surgery. Q: Can I drink alcohol while taking Evergraf 0.25mg tablet? A: It is generally recommended to avoid drinking alcohol while taking Evergraf 0.25mg tablet, as alcohol can increase the risk of liver damage.
- Medicine interaction:
- Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Evergraf 0.25mg tablet and reduce effectiveness by causing undesirable side effects.
